Dedicated to making life better for people living with underserved disorders with high unmet medical needs

Learn More

Leveraging our proprietary fibroblast technology platform to create personalized cell and gene therapies

Learn More

personalized biologics approach

Our focus on the patient drives everything we do and as a result, our path forward is clear: to develop game-changing cell and gene therapies for localized treatment of underserved disorders with high unmet medical needs.

— John Maslowski, Chief Executive Officer

Our robust development pipeline of personalized therapies for localized treatment

Applying the unique characteristics of autologous fibroblasts to develop innovative cell and gene therapies

Photo left: Courtesy of debra–The Dystrophic Epidermolysis Bullosa Research Association of America. Used with permission.
Photo right: Courtesy of debra–The Dystrophic Epidermolysis Bullosa Research Association of America. Used with permission.

    patient8-287x284patient14-189x284patient1-287x284patient13-228x284inset-patient-RDEB-476-284 patient6-315x284patient4-322x284